Prognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximab

Antiangiogenic Therapies in Non-Hodgkin's Lymphoma

(2011) J. Ruan   CURRENT CANCER DRUG TARGETS

CD40 stimulation sensitizes CLL cells to rituximab-induced cell death

(2011) M Jak et al.   LEUKEMIA

Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?

(2011) Jung A. Kim et al.   LEUKEMIA & LYMPHOMA

Hypoxia-Inducible Factor-1 α Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

(2009) S Rasheed et al.   BRITISH JOURNAL OF CANCER

Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor Expression are Associated with a Poor Prognosis in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy with Carbogen and Nicotinamide

(2008) Lu Xueguan et al.   CLINICAL ONCOLOGY

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation

(2008) Alexandra Giatromanolaki et al.   HEMATOLOGICAL ONCOLOGY

Regulation of cancer cell metabolism by hypoxia-inducible factor 1

(2008) Gregg L. Semenza   SEMINARS IN CANCER BIOLOGY

Regulation of CD20 expression by radiation-induced changes in intracellular redox status

(2007) Damodar Gupta et al.   FREE RADICAL BIOLOGY AND MEDICINE